ProfileGDS4718 / 1554732_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 32% 35% 31% 36% 30% 32% 36% 33% 34% 33% 34% 38% 32% 29% 35% 32% 32% 34% 36% 29% 38% 34% 33% 33% 35% 38% 34% 31% 25% 34% 41% 36% 44% 35% 38% 27% 35% 35% 39% 34% 35% 35% 35% 30% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.6507532
GSM549102patient 115, normal, homogenized [OPG study]4.7568235
GSM549104patient 119, normal, homogenized [OPG study]4.5601931
GSM549108patient 138, normal, homogenized [OPG study]4.8549136
GSM549119patient 077, normal, homogenized [OPG study]4.5531230
GSM549133patient 032, cancer, homogenized [OPG study]4.5589632
GSM549139patient 042, cancer, homogenized [OPG study]4.7906636
GSM549099patient 107, normal, homogenized [OPG study]4.6903633
GSM549109patient 139, normal, homogenized [OPG study]4.7170434
GSM549110patient 046, normal, homogenized [OPG study]4.6794433
GSM549114patient 063, normal, homogenized [OPG study]4.6503234
GSM549122patient 082, normal, homogenized [OPG study]4.9035638
GSM549134patient 033, cancer, homogenized [OPG study]4.6363932
GSM549136patient 036, cancer, homogenized [OPG study]4.4369429
GSM549140patient 044, cancer, homogenized [OPG study]4.7364135
GSM549111patient 047, normal, homogenized [OPG study]4.5911732
GSM549113patient 057, normal, homogenized [OPG study]4.5635732
GSM549132patient 031, cancer, homogenized [OPG study]4.7102934
GSM549137patient 038, cancer, homogenized [OPG study]4.7789336
GSM549142patient 047, cancer, homogenized [OPG study]4.6317229
GSM549100patient 110, normal, homogenized [OPG study]4.9253738
GSM549107patient 135, normal, homogenized [OPG study]4.6848434
GSM549115patient 068, normal, homogenized [OPG study]4.6092933
GSM549116patient 072, normal, homogenized [OPG study]4.6264733
GSM549120patient 078, normal, homogenized [OPG study]4.759735
GSM549131patient 030, cancer, homogenized [OPG study]4.832938
GSM549118patient 074, normal, homogenized [OPG study]4.702134
GSM549129patient 027, cancer, homogenized [OPG study]4.6025531
GSM549123patient 088, normal, homogenized [OPG study]4.3313825
GSM549124patient 006, cancer, homogenized [OPG study]4.7521234
GSM549126patient 015, cancer, homogenized [OPG study]5.0455241
GSM549128patient 025, cancer, homogenized [OPG study]4.7644536
GSM549103patient 117, normal, homogenized [OPG study]5.2552844
GSM549117patient 073, normal, homogenized [OPG study]4.7224135
GSM549138patient 041, cancer, homogenized [OPG study]4.8997538
GSM549141patient 045, cancer, homogenized [OPG study]4.3457527
GSM549130patient 028, cancer, homogenized [OPG study]4.7837735
GSM549101patient 111, normal, homogenized [OPG study]4.7981935
GSM549105patient 128, normal, homogenized [OPG study]4.9665139
GSM549106patient 134, normal, homogenized [OPG study]4.6600934
GSM549112patient 048, normal, homogenized [OPG study]4.734235
GSM549125patient 011, cancer, homogenized [OPG study]4.78235
GSM549127patient 024, cancer, homogenized [OPG study]4.7307935
GSM549135patient 035, cancer, homogenized [OPG study]4.5108530